An anticoagulation option for nonvalvular atrial fibrillation.
Division of Cardiology, Department of Internal Medicine, University of Tennessee Health Sciences Center, Memphis, TN 38104, USA.
Mazen H
MH
Shaheen
Pranab
P
Das
Santhosh K G
SK
Koshy
Sunil K
SK
Jha
Rajesh
R
Kabra
D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D001562:Benzimidazoles / Q000627:therapeutic use*; D000069604:Dabigatran; D003661:Decision Support Techniques; D006305:Health Status Indicators; D006801:Humans; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin; D000069604:Dabigatran